A Comparative Analysis of Efficacy of Rituximab in Patients with Primary Membranous Nephropathy

被引：0
|
作者：
Zhang Qianwei [1 ]
Xie Liyi [1 ]
机构：
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2024年 / 35卷 / 10期
关键词：
D O I：
10.1681/ASN.2024g2wf30dz
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
TH-PO591
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Rituximab treatment of idiopathic membranous nephropathy
    Fervenza, F. C.
    Cosio, F. G.
    Erickson, S. B.
    Specks, U.
    Herzenberg, A. M.
    Dillon, J. J.
    Leung, N.
    Cohen, I. M.
    Wochos, D. N.
    Bergstralh, E.
    Hladunewich, M.
    Cattran, D. C.
    KIDNEY INTERNATIONAL, 2008, 73 (01) : 117 - 125
  • [42] Rituximab for idiopatic membranous nephropathy (IMN).
    Remuzzi, G
    Chiurchiu, C
    Abbate, M
    Brusegan, V
    Bontempelli, M
    Ruggenenti, P
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 15A - 15A
  • [43] Rituximab better for idiopathic membranous nephropathy?
    Marckmann, Peter
    NEPHROLOGY, 2018, 23 (07) : 706 - 707
  • [44] Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
    Fervenza, F. C.
    Appel, G. B.
    Barbour, S. J.
    Rovin, B. H.
    Lafayette, R. A.
    Aslam, N.
    Jefferson, J. A.
    Gipson, P. E.
    Rizk, D. V.
    Sedor, J. R.
    Simon, J. F.
    McCarthy, E. T.
    Brenchley, P.
    Sethi, S.
    Avila-Casado, C.
    Beanlands, H.
    Lieske, J. C.
    Philibert, D.
    Li, T.
    Thomas, L. F.
    Green, D. F.
    Juncos, L. A.
    Beara-Lasic, L.
    Blumenthal, S. S.
    Sussman, A. N.
    Erickson, S. B.
    Hladunewich, M.
    Canetta, P. A.
    Hebert, L. A.
    Leung, N.
    Radhakrishnan, J.
    Reich, H. N.
    Parikh, S. V.
    Gipson, D. S.
    Lee, D. K.
    da Costa, B. R.
    Juni, P.
    Cattran, D. C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (01): : 36 - 46
  • [45] Rituximab for the management of idiopathic membranous nephropathy: a meta-analysis
    Lan Huang
    Qiao-Rong Dong
    Ya-Juan Zhao
    Gui-Cai Hu
    International Urology and Nephrology, 2021, 53 : 111 - 119
  • [46] Rituximab for the management of idiopathic membranous nephropathy: a meta-analysis
    Huang, Lan
    Dong, Qiao-Rong
    Zhao, Ya-Juan
    Hu, Gui-Cai
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (01) : 111 - 119
  • [47] Rituximab or Cyclosporine for Membranous Nephropathy REPLY
    Fervenza, Fernando C.
    Cattran, Daniel C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (17): : 1689 - 1690
  • [48] RETRACTED: Efficacy and Safety of Rituximab in the Treatment of Idiopathic Membranous Nephropathy: A Meta-Analysis (Retracted Article)
    Lu, Huijuan
    Shen, Jun
    Sun, Jieqiong
    Sun, Jia
    APPLIED BIONICS AND BIOMECHANICS, 2022, 2022
  • [49] Primary membranous nephropathy
    Infantino, Maria
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [50] Different Dosage Regimens of Rituximab in Primary Membranous Nephropathy Treatment: A Systematic Review
    Yu, Yi
    Xu, Ricong
    Li, Zhijian
    Wan, Qijun
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2024, 17 : 265 - 273
12345